Skip to main content
Premium Trial:

Request an Annual Quote

Variagenics Licenses Disease Gene to Commercial Lab for Risk Test

NEW YORK, Oct. 10 - Variagenics said today it granted nonexclusive commercialization rights to ARUP Laboratories to develop a home brew test for an allele associated with risk for cardiovascular disease.


Variations in the human methylenetetrahydrofolate reductase gene are associated with increased risk for cardiovascular disease, central nervous system disorders, osteoporosis, disorders influenced by folic acid metabolism, and cancer, according to Variagenics.


Financial details of the agreement with ARUP, a full-service clinical reference laboratory based in Salt Lake City, were not disclosed.


Variagenics obtained patent rights for the MTHFR gene in 1999 from McGillUniversity.


Click here for more information.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.